Epineuron announces Health Canada approval of the PeriPulse™ system for nerve regeneration

Epineuron is excited to announce Health Canada approval of its innovative nerve regeneration system, the PeriPulse™. Building on the success of its multi-center first in-human clinical trial, surgeons in Canada now have access to the only therapeutic solution designed to enhance nerve regeneration, providing best-in-class care for patients with severe nerve injuries and chronic neurological conditions.

The PeriPulse™ nerve stimulation system uses an advanced shapeable electrode and a patient wearable, allowing for quick deployment at the end of surgery. This enables delivery of the well-established one hour electrical stimulation therapy in the recovery room, cutting time spent in the operating room by about 95%.

Epineuron is an alumnus of the HealthMINT™, CAAP®, H2BB™, BDSP™ and WiHI programs, and presented at the OBIO® Investment Summit.